Skin Biopsy is a Practical Approach for the Clinical Diagnosis and Molecular Genetic Analysis of X-linked Alport's Syndrome.

Fang Wang,Dan Zhao,Jie Ding,Hongwen Zhang,Yanqin Zhang,Lixia Yu,Huijie Xiao,Yong Yao,Xuhui Zhong,Suxia Wang
DOI: https://doi.org/10.1016/j.jmoldx.2012.06.005
IF: 5.341
2012-01-01
Journal of Molecular Diagnostics
Abstract:A total of 209 unrelated patients of predominantly Han Chinese ethnicity and with X-linked Alport's syndrome, a clinically heterogeneous hereditary nephritis, were enrolled in the present study to evaluate the ability to make a clinical diagnosis and perform molecular genetics analysis using skin biopsy. A negative or mosaic α5(IV) chain staining in the epidermal basement membrane was detected in 86.2% of male and 93.5% of female patients. COL4A5 mutations were identified in 85% of male patients with a negative α5(IV) chain staining pattern in the epidermal basement membrane. With use of skin biopsy and immunostaining, 16.4% of our patients were diagnosed before 3 years of age, and the youngest was diagnosed at 1 year of age. COL4A5 mutations were detected in 22 patients with normal epidermal basement membrane staining for the α5(IV) chain. Analysis of COL4A5 cDNA fragments from skin fibroblasts yielded a mutation detection rate of 83%, which was particularly valuable for identification of cryptic splicing mutations. Furthermore, 83% of COL4A5 mutations identified in the present study were novel. Thus, skin biopsy is a practical approach for the clinical diagnosis and molecular genetic analysis of X-linked Alport's syndrome.
What problem does this paper attempt to address?